SDSDownload

Val-Ala-PAB / 500 mg

Synonym: L-Valyl-N-[4-(hydroxymethyl)phenyl]-L-alaninamide; (2S)-2-amino-N-[(2S)-1-[4-(hydroxymethyl)anilino]-1-oxopropan-2-yl]-3-methylbutanamide; (S)-2-Amino-N-((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-yl)-3-methylbutanamide
Molecular Formula: C15H23N3O3
Molecular Weight: 293.36
SKU: MND-190069
CAS Number: 1343476-44-7
PubChem: 68223172
Packing size: 500 mg  


Properties

Signal WordWarning

 Product Description

Val-Ala-PAB is a specialized chemical compound designed for specific applications within the scientific research community. It is known for its unique properties that make it suitable for various laboratory experiments and analytical procedures. This compound plays a crucial role in enhancing the efficiency and accuracy of certain reactions, making it an essential tool for researchers working in fields such as biochemistry, pharmaceuticals, and environmental science. Its precise formulation ensures stability under controlled conditions, allowing for consistent performance across different experimental setups.

 

Application

Val-Ala-PAB finds its primary application in biochemical assays where it acts as a substrate or reagent. Its ability to participate in specific enzymatic reactions makes it invaluable for enzyme activity measurements and kinetic studies. Additionally, it can be utilized in the development of new diagnostic tools and therapeutic agents, contributing to advancements in medical research and drug discovery processes.

 

 

Articles:

- Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system

Publication Date: Available online 5 April 2009

Patrick J. Burke, Brian E. Toki, David W. Meyer, Jamie B. Miyamoto, Kim M. Kissler, Martha Anderson, Peter D. Senter, Scott C. Jeffrey

https://doi.org/10.1016/j.bmcl.2009.03.145

 

- Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery

Publication Date: Available online 8 November 2018

Daniel A. Richards

https://doi.org/10.1016/j.ddtec.2018.10.005

 

- Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers

Publication Date: 25 December 2021

Dr. Cheng Jin, Dr. Afaf H. EI-Sagheer, Siqi Li, Prof. Katherine A. Vallis, Prof. Weihong Tan, Prof. Tom Brown

https://doi.org/10.1002/ange.202114016